Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCHB
1026
Mechanics Bancorp
MCHB
$3.8B
| $13.9M | 0.01% |
565,100
-2,600
| -0.5% | -$60.4K |
|
|
ELP
1027
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $13.9M | 0.01% |
3,060,250
-2,093,250
| -41% | -$9.26M |
|
|
DRRX
1028
DELISTED
DURECT Corp
DRRX
| $13.9M | 0.01% |
598,970
+78,149
| +15% | +$1.72M |
|
1029
West Pharmaceutical
WST
$24.8B
| $13.9M | 0.01% |
61,100
-304,100
| -83% | -$59.8M |
|
1030
Hilltop Holdings
HTH
$2.25B
| $13.9M | 0.01% |
751,000
-200,384
| -21% | -$3.44M |
|
|
MNTA
1031
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.8M | 0.01% |
416,251
+359,237
| +630% | +$11.4M |
|
1032
NiSource
NI
$20.1B
| $13.8M | 0.01% |
607,300
-1,234,631
| -67% | -$29.8M |
|
1033
AptarGroup
ATR
$8.43B
| $13.8M | 0.01% |
123,300
+95,200
| +339% | +$10.1M |
|
|
ZIXI
1034
DELISTED
Zix Corporation
ZIXI
| $13.8M | 0.01% |
1,999,094
-509,100
| -20% | -$3.08M |
|
|
EVRI
1035
DELISTED
Everi Holdings
EVRI
| $13.7M | 0.01% |
2,662,500
-274,600
| -9% | -$1.39M |
|
1036
SunCoke Energy
SXC
$788M
| $13.7M | 0.01% |
4,640,433
-600,318
| -11% | -$1.92M |
|
1037
Oil-Dri
ODC
$1.27B
| $13.7M | 0.01% |
791,492
+31,800
| +4% | +$551K |
|
1038
Landstar System
LSTR
$6.4B
| $13.7M | 0.01% |
122,240
+37,700
| +45% | +$4.03M |
|
|
MIME
1039
DELISTED
Mimecast Limited
MIME
| $13.7M | 0.01% |
329,400
+291,200
| +762% | +$11.4M |
|
|
UBA
1040
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $13.7M | 0.01% |
1,155,022
-266,900
| -19% | -$3.43M |
|
|
LITS
1041
Lite Strategy Inc
LITS
$31.4M
| $13.7M | 0.01% |
165,624
+12,515
| +8% | +$759K |
|
|
CNBKA
1042
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $13.6M | 0.01% |
175,603
-4,998
| -3% | -$349K |
|
|
LGF.A
1043
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $13.6M | 0.01% |
1,841,678
-102,100
| -5% | -$756K |
|
1044
Deluxe
DLX
$1.09B
| $13.6M | 0.01% |
578,310
+96,000
| +20% | +$2.41M |
|
1045
TriMas Corp
TRS
$1.41B
| $13.6M | 0.01% |
568,270
-7,200
| -1% | -$165K |
|
1046
Kemper
KMPR
$1.56B
| $13.6M | 0.01% |
187,236
-39,900
| -18% | -$2.67M |
|
1047
Ironwood Pharmaceuticals
IRWD
$674M
| $13.6M | 0.01% |
1,313,853
-184,600
| -12% | -$1.89M |
|
1048
Nathan's Famous
NATH
$397M
| $13.5M | 0.01% |
240,820
-3,500
| -1% | -$199K |
|
|
AMED
1049
DELISTED
Amedisys
AMED
| $13.5M | 0.01% |
68,201
-100,500
| -60% | -$18.7M |
|
1050
Agilysys
AGYS
$3.03B
| $13.5M | 0.01% |
753,552
+92,903
| +14% | +$1.74M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.